Aclaris Therapeutics(DE:8AT)
€3.58-0.31 (-7.88%)
DE:8AT
Aclaris Therapeutics earnings date
€3.58
At close:-0.31 (-7.88%)
Aclaris Therapeutics (8AT) Q2 2026 Earnings Report
1 Followers
DE:8AT Q2 2026 EPS Results
- Actual EPS
- -EUR 0.14
- Consensus EPS
- -EUR 0.15
- Beat/Miss
- Beat by +EUR 0.01
- One Year Ago EPS
- -EUR 0.12
DE:8AT Q2 2026 Revenue Results
- Actual Revenue
- EUR 1.48M
- Expected Revenue
- EUR 1.25M
- Beat/Miss
- Beat by +EUR 223.16K
- YoY Revenue Growth
- -8.33%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/06/2026
- Time
- Before Open
- Conference Call
- Thursday, August 6, 2026
DE:8AT Upcoming Earnings
Aclaris Therapeutics's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:8AT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | -0.15- | -0.15 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.15-0.11 | -0.11 | 0.00% (+0.00) | |
| Aug 06, 2026 | 2026 (Q2) | -0.15-0.14 | -0.12 | -15.38% (-0.02) | |
| May 12, 2026 | 2026 (Q1) | -0.14-0.14 | -0.11 | -25.00% (-0.03) | |
| Feb 26, 2026 | 2025 (Q4) | -0.13-0.15 | -0.92 | 84.16% (+0.77) | |
| Nov 05, 2025 | 2025 (Q3) | -0.12-0.11 | -0.1 | -9.09% (-0.01) | |
| Aug 06, 2025 | 2025 (Q2) | -0.12-0.12 | -0.14 | 13.33% (+0.02) | |
| May 08, 2025 | 2025 (Q1) | -0.14-0.11 | -0.22 | 50.00% (+0.11) | |
| Feb 27, 2025 | 2024 (Q4) | -0.26-0.92 | -0.02 | -4950.00% (-0.90) | |
| Nov 06, 2024 | 2024 (Q3) | -0.01-0.10 | -0.37 | 73.17% (+0.27) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
